These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37167823)

  • 1. Wen-Shen-Jian-Pi-Hua-Tan decoction protects against early obesity-related glomerulopathy by improving renal bile acid composition and suppressing lipogenesis, inflammation, and fibrosis.
    Song D; Zhang A; Hu X; Zeng M; Zhou H
    Phytomedicine; 2023 Jul; 116():154861. PubMed ID: 37167823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coptidis Rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy.
    Ren Y; Wang D; Lu F; Zou X; Xu L; Wang K; Huang W; Su H; Zhang C; Gao Y; Dong H
    Phytomedicine; 2018 Oct; 49():52-65. PubMed ID: 30217262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.
    Wang XX; Jiang T; Shen Y; Adorini L; Pruzanski M; Gonzalez FJ; Scherzer P; Lewis L; Miyazaki-Anzai S; Levi M
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1587-96. PubMed ID: 19776172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jian-Pi-Yi-Shen formula ameliorates renal fibrosis-induced anemia in rats with chronic kidney disease.
    Huang H; Huang S; Li C; Zhang C; Wang R; Wei L; Wu J; Mo P; Li Z; Li S; Chen J
    J Ethnopharmacol; 2024 Dec; 335():118607. PubMed ID: 39069029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin differentially regulates bile acid metabolism and intestinal FXR-bile acid transporter axis in response to nutrient abundance.
    Li J; Song J; Yan B; Weiss HL; Weiss LT; Gao T; Evers BM
    FASEB J; 2021 May; 35(5):e21371. PubMed ID: 33811694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying hepatoprotective mechanism and effective components of Yinchenzhufu decoction in chronic cholestatic liver injury using a comprehensive strategy based on metabolomics, molecular biology, pharmacokinetics, and cytology.
    Li Y; Peng X; Wang G; Zan B; Wang Y; Zou J; Tian T; Meng Q; Shi R; Wang T; Wu J; Ma Y
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117060. PubMed ID: 37598769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-related glomerulopathy is associated with elevated WT1 expression in podocytes.
    Jakhotia S; Kavvuri R; Raviraj S; Baishya S; Pasupulati AK; Reddy GB
    Int J Obes (Lond); 2024 Aug; 48(8):1080-1091. PubMed ID: 38504059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
    Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
    Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet-induced obesity and weight loss alter bile acid concentrations and bile acid-sensitive gene expression in insulin target tissues of C57BL/6J mice.
    La Frano MR; Hernandez-Carretero A; Weber N; Borkowski K; Pedersen TL; Osborn O; Newman JW
    Nutr Res; 2017 Oct; 46():11-21. PubMed ID: 29173647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
    Wang S; Sheng F; Zou L; Xiao J; Li P
    J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
    Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
    Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
    Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
    Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis.
    Liu J; Liu J; Meng C; Huang C; Liu F; Xia C
    Phytomedicine; 2022 Jul; 102():154173. PubMed ID: 35605478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed Wistar rats.
    Hu Z; Ren L; Wang C; Liu B; Song G
    Kidney Blood Press Res; 2012; 36(1):85-97. PubMed ID: 22948014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nifedipine Exacerbates Lipogenesis in the Kidney via KIM-1, CD36, and SREBP Upregulation: Implications from an Animal Model for Human Study.
    Lin YC; Wang JC; Wu MS; Lin YF; Chen CR; Chen CY; Chen KC; Peng CC
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Obesity Effects of Aster spathulifolius Extract in High-Fat Diet-Induced Obese Rats.
    Kim SJ; Bang CY; Guo YR; Choung SY
    J Med Food; 2016 Apr; 19(4):353-64. PubMed ID: 26908215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-κB and ERK/p38 MAPK-dependent inflammation.
    Guo YP; Jiang HK; Jiang H; Tian HY; Li L
    Life Sci; 2018 Apr; 198():112-118. PubMed ID: 29499280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red ginseng ameliorates lipotoxicity-induced renal fibrosis in hyperuricemia mice.
    Zhang YL; Chen SM; Song YJ; Islam MA; Rao PL; Zhu MJ; Gu WY; Xu Y; Xu HX
    J Ethnopharmacol; 2024 Jun; 327():118014. PubMed ID: 38460576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.